SAPODERM DIN 00120103
Health Canada record
| Active ingredient(s) | HEXACHLOROPHENE 2 % |
|---|---|
| Dosage form | Liquid |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D08AE01 HEXACHLOROPHENE |
| Original market date | 31-Dec-1952 |
| Current status date | 05-Aug-1999 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HEXACHLOROPHENE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00120847 | HEXAPHENYL | INGRAM AND BELL INC. | Liquid | HEXACHLOROPHENE 1 %; ISOPROPYL ALCOHOL 9 % | Cancelled Post Market |
| 02017733 | PHISOHEX | SANOFI-AVENTIS CANADA INC | Emulsion | HEXACHLOROPHENE 3 % | Cancelled Post Market |
International API supply for HEXACHLOROPHENE
0 active FDA Drug Master Files.
Request a quote for SAPODERM